Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$33.21 - $46.54 $566,529 - $793,925
-17,059 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$33.87 - $55.93 $209,858 - $346,542
6,196 Added 57.04%
17,059 $597,000
Q4 2017

Feb 14, 2018

SELL
$52.12 - $72.33 $1.94 Million - $2.69 Million
-37,248 Reduced 77.42%
10,863 $659,000
Q2 2017

Aug 14, 2017

BUY
N/A
48,111
48,111 $2.52 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.04B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.